Nox Medical (NOX) was founded in 2006 by engineers, investors and medical professionals with extensive experience in providing industry standard solutions for sleep monitoring and diagnostics. The main goal of the company is to bring to the market a new generation of products to support the growth of sleep medicine with easy-to-use solutions, embraced by established practitioners. NOX launched its first major product in 2009, the revolutionary portable sleep monitor called NOX T3, based on the latest innovations in wireless technology, memory, sensors and electronics. In 2011, the disposable NOX respiratory inductance plethysmography (RIP) Belts and the NOX Nasal Cannula were launched to complete our line of products for the NOX T3 device. In 2013, NOX launched its next generation in ambulatory PSG systems, the NOX A1 System based on similar design principles as the NOX T3. In 2017, a full wireless in-lab sleep system NOX C1 was launched and in 2018 a full self-applied somnography (SAS) system for research studies. In 2020, we released the NOX T3s, a respiratory sleep monitor with machine learned sleep-staging based on the respiratory signals. NOX products are available worldwide through our distribution partnerships. The NOX mission is to improve health by improving sleep diagnostics by making it more simple, efficient and comfortable in all patient groups, including children.